Evidence map›Paper›PMID 33767933›Full record

ArticleCureus2021

Assessment of Medication Dosage Adjustment in Hospitalized Patients With Chronic Kidney Disease.

Zair Hassan, Iftikhar Ali, Arslan R Ullah, Raheel Ahmed, Adnan Zar, Irfan Ullah, Shakeel Rehman, Aziz Ullah Khan, Rizwan Ullah, Muhammad Hanif

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Zair HassanCardiology, Lady Reading Hospital, Peshawar, PAK.
Iftikhar AliPharmacy, Paraplegic Center, Peshawar, PAK.
Arslan R UllahInternal Medicine, Northwest General Hospital & Research Centre, Peshawar, PAK.
Raheel AhmedNephrology, Institute of Kidney Diseases, Peshawar, PAK.
Adnan ZarInternal Medicine, Lady Reading Hospital, Peshawar, PAK.
Irfan UllahInternal Medicine, Kabir Medical College, Peshawar, PAK.
Shakeel RehmanPharmacy, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Peshawar, PAK.
Aziz Ullah KhanPharmacy, Lady Reading hospital, Peshawar, PAK.
Rizwan UllahCardiology, Lady Reading Hospital, Peshawar, PAK.
Muhammad HanifInternal Medicine, Khyber Medical College Peshawar, Hayatabad Medical Complex, Peshawar, PAK.
Shaukat Khanum Memorial Cancer Hospital and Research Center · PKSwiss Paraplegic Center · CHLady Reading Hospital · PKNorthwest General Hospital and Research Center · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Inappropriate medication dosing can cause adverse drug reactions or ineffective therapy due to declined renal function in patients with renal insufficiency. This necessitates proper renal dose adjustment. This study was proposed to evaluate medication dosage adjustment in hospitalized chronic kidney disease (CKD) patients. Methods This study included all CKD patients hospitalized between May 1, 2019, and April 25, 2020, at the Institute of Kidney Disease, Peshawar, Pakistan. The estimated glomerular filtration rate was calculated using the Modification of Diet in Renal Disease formula, and dose appropriateness was established by evaluating practice with relevant reference books. Results Of the total 1,537 CKD patients, 231 (15.03%) had evidence of dosing error, which was considered for final analysis. Overall, 1,549 drugs were prescribed; 480 (30.99%) drugs required dose adjustment, of which 196 (40.42%) were adjusted properly and the remaining 286 (59.58%) were unadjusted. The most common unadjusted drugs were meropenem, cefepime, ciprofloxacin, and rosuvastatin, whereas captopril, aspirin, bisoprolol, pregabalin, and levofloxacin had the highest percentage of adjusted drugs. On multivariate logistic regression, the number of drugs requiring dosing adjustments and obstructive nephropathy were found to be statistically significant factors that increased the likelihood of the medication dosing errors: a unit increase in the number of drugs requiring dose adjustment increases 5.241 times the likelihood of dosing error. Similarly, the presence of obstructive nephropathy (OR: 0.383; 95% Cl: 0.153-0.960; p = 0.041) was found to be significantly associated with dosing error after adjustment for potential confounding factors. Conclusion The dosing of more than half of the prescribed drugs that required adjustment in CKD patients was not adjusted, which showed that medication dosing errors were high. This highlights the importance of medication prescription according to guidelines in these patients to improve the outcomes of pharmacotherapy.

Indexed as

chronic kidney diseasedose adjustmentmedication errorsrenal impairment

Identifiers

PMID33767933
PMCPMC7982869
OpenAlexW3129562214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.